This page includes the latest FDA filings for Syndax Pharmaceuticals Inc. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| USA | NASDAQ | SNDX | DUNS 944546089 |
Device Company | Device | Date |
|---|---|---|
| Syndax Pharmaceuticals, Inc. | Prescription Medication | 2025-12-07 |
| Syndax Pharmaceuticals, Inc. | Prescription Medication | 2025-11-07 |
| Syndax Pharmaceuticals, Inc. | Prescription Medication | 2025-04-26 |
| Syndax Pharmaceuticals, Inc. | Prescription Medication | 2024-11-27 |
| NCAGE Code | 63QE1 | SYNDAX PHARMACEUTICALS INC |
| CAGE Code | 63QE1 | SYNDAX PHARMACEUTICALS INC |
| DUNS | 944546089 | SYNDAX PHARMACEUTICALS INC |
| SEC | 0001395937 | Syndax Pharmaceuticals Inc of DELAWARE |